Asston Pharmaceuticals IPO

About the company

Incorporated in 2019, Asston Pharmaceuticals manufactures and exports pharmaceutical formulations and nutraceutical products for domestic and African markets. It operates through export sales, contract manufacturing/license sales, and domestic sales. The company’s Ambernath facility has a capacity of 8-9 crore tablets/month (currently 5-6 crore), 37.5 KL/month syrup, and 30-40 lakh sachets/month. It has five WHO-GMP-certified contract manufacturers under 5-year agreements and holds 150+ trademarks. Asston has 147 product registrations in African markets (Sierra Leone, Mali, Liberia, Ghana) and 10 filed in Cambodia, covering tablets, syrups, capsules, sachets, ophthalmic products, and creams. As of May 31, 2025, its order book stands at $4.75 million (₹40.86 crore) from 12 customers.

Financial performance (₹ Cr)

Subscription breakup (final, times)

IPO Roadmap / Timeline

1. IPO Opens

   Completed
   09 Jul 2025

   Bidding starts for all investor categories

2. IPO Closes

   Completed
   11 Jul 2025

   Last day to place your bid

3. Basis of Allotment

   Completed
   14 Jul 2025

   Share allotment finalised

4. Refund Initiation

   Completed
   15 Jul 2025

   Refunds credited for non-allottees

5. Credit to Demat

   Completed
   15 Jul 2025

   Allotted shares credited to demat account

6. Listing on Exchange

   Completed
   16 Jul 2025

   Shares list on NSE / BSE

Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.